| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $41.27M | - | |
| CEO | 875.0K | $40.56M | - | |
| Other | 740.2K | $34.31M | - | |
| 10% | 245.7K | $11.39M | -281,408 | |
| COO | 215.0K | $9.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $15.81 | $51,388.35 | -100% | +7.5% | +27.1% | |
| Jan 25, 2024 | Kintz Samuel51 | President And CEO | Sale+OE | 12,000 | $15.69 | $188,229.50 | -55.9% | +7.0% | +33.8% | |
| Jan 22, 2024 | Patel Anish54 | Chief Operating Officer | Sell | 4,875 | $15.14 | $73,783.13 | -22.1% | +19.6% | +49.4% | |
| Jan 2, 2024 | Patel Anish54 | Chief Operating Officer | Sell | 13,540 | $15.02 | $203,348.35 | -13.3% | +26.8% | +60.4% | |
| Jan 2, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 11,870 | $15.02 | $178,326.88 | -100% | +26.8% | +60.4% | |
| Dec 29, 2023 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sale+OE | 12,000 | $14.28 | $171,381.29 | -80.8% | +27.1% | +61.6% | |
| Dec 26, 2023 | Kintz Samuel51 | President And CEO | Sale+OE | 12,000 | $14.64 | $175,708.80 | -100% | +22.7% | +56.7% | |
| Dec 26, 2023 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 1,130 | $15.07 | $17,024.98 | -100% | +22.7% | +56.7% | |
| Dec 26, 2023 | Patel Anish54 | Chief Operating Officer | Sell | 1,085 | $15.03 | $16,306.28 | -1.5% | +22.7% | +56.7% | |
| Dec 22, 2023 | Kintz Samuel51 | President And CEO | Sale+OE | 8,195 | $13.05 | $106,915.14 | -100% | +21.6% | +51.3% |